Challenges in the Regulation of High-Cost Treatments—An Overview From Brazil

Challenges in the Regulation of High-Cost Treatments—An Overview From Brazil

Regulation of drug prices that ensures adequate access to effective treatments and promotes innovation is a global challenge. In the United States, the government does not regulate drug prices when they come onto market. On the other hand, in countries such as France and Brazil, government agencies...

Full description

Bibliographic Details
Main Authors: Ayad, N.M.E (Author), Cortopassi, W.A (Author), Khuri, N. (Author), Ortiz, J. (Author), Pereira, L.C (Author), Safatle, L.P (Author), Sturzenegger, D.V.R (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2019
Subjects:
Article
Brazil
budget
cost control
Cost Control
Delivery of Health Care
drug cost
Drug Costs
drug efficacy
drug pricing
drug safety
economics
government regulation
Government Regulation
health care access
health care cost
health care delivery
health care organization
health care policy
health care system
human
Humans
international cooperation
International Cooperation
judicialization of health
legislation and jurisprudence
organization and management
priority journal
procedures
rare disease
Rare Diseases
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items